loadpatents
Patent applications and USPTO patent grants for Steinmetz; Heinrich.The latest application filed is for "cystobactamides".
Patent | Date |
---|---|
Crystobactamides Grant 11,225,503 - Baumann , et al. January 18, 2 | 2022-01-18 |
Cystobactamides App 20200331964 - Baumann; Sascha ;   et al. | 2020-10-22 |
Cystobactamides Grant 10,793,600 - Baumann , et al. October 6, 2 | 2020-10-06 |
Novel Macrolide Antibiotics App 20200231562 - Surup; Frank ;   et al. | 2020-07-23 |
Cystobactamides Grant 10,519,099 - Baumann , et al. Dec | 2019-12-31 |
Cystobactamides App 20190185514 - Baumann; Sascha ;   et al. | 2019-06-20 |
Novel Cystobactamides App 20170327458 - Baumann; Sascha ;   et al. | 2017-11-16 |
Neosoraphens App 20170029436 - Mueller; Rolf ;   et al. | 2017-02-02 |
Cystobactamides App 20160145304 - Baumann; Sascha ;   et al. | 2016-05-26 |
Pharmaceutical composition effective against biofilms Grant 8,841,341 - Kunze , et al. September 23, 2 | 2014-09-23 |
Haprolid and Derivatives Thereof as Inhibitors of HCV App 20140256618 - Pietschmann; Thomas ;   et al. | 2014-09-11 |
Use of inhibitors of the degradation of p27, in particular Argyrin and derivatives thereof, for the treatment of proliferative diseases Grant 8,217,071 - Malek , et al. July 10, 2 | 2012-07-10 |
Epothilones C, D, E, and F, preparation and compositions Grant 8,076,490 - Reichenbach , et al. December 13, 2 | 2011-12-13 |
Epothilones C, D, E, And F, Preparation And Compositions App 20110136185 - REICHENBACH; HANS ;   et al. | 2011-06-09 |
Elansolids, Novel Natural Metabolites of Flexibacter and Antibiotically Active Derivatives Thereof App 20110034528 - Gerth; Klaus ;   et al. | 2011-02-10 |
Pharmaceutical Composition Effective Against Biofilms App 20110034708 - Kunze; Brigitte ;   et al. | 2011-02-10 |
Epothilones C, D, E, and F, preparation and compositions Grant 7,846,952 - Reichenbach , et al. December 7, 2 | 2010-12-07 |
Epothilones C, D, E, and F, preparation and compositions Grant 7,759,375 - Reichenbach , et al. July 20, 2 | 2010-07-20 |
Tubulysins, method for producing the same and tubulysin preparations Grant 7,754,885 - Hoefle , et al. July 13, 2 | 2010-07-13 |
Use of Inhibitors of the Degradation of P27, in Particular Argyrin and Derivatives Thereof, for the Treatment of Proliferative Diseases App 20100144822 - Malek; Nisar ;   et al. | 2010-06-10 |
Epothilones C, D, E, and F, Preparation and Compositions App 20090270466 - Reichenbach; Hans ;   et al. | 2009-10-29 |
Epothilones C, D, E, and F, Preparation and Compositions App 20090247592 - Reichenbach; Hans ;   et al. | 2009-10-01 |
Epothilones C, D, E And F, Preparation And Compositions App 20080293784 - Hoefle; Gerhard ;   et al. | 2008-11-27 |
Epothilone side components Grant 7,235,669 - Hoefle , et al. June 26, 2 | 2007-06-26 |
Epothilones C, D, E and F, preparation and compositions App 20060264482 - Hoefle; Gerhard ;   et al. | 2006-11-23 |
Epothilone side components App 20060142584 - Hoefle; Gerhard ;   et al. | 2006-06-29 |
Epothilones C, D, E and F, preparation and compositions Grant 7,067,544 - Hoefle , et al. June 27, 2 | 2006-06-27 |
Tubulysins, method for producing the same and tubulysin preparations App 20060128754 - Hoefle; Gerhard ;   et al. | 2006-06-15 |
Epothilones C, D, E and F, preparation and compositions App 20050090535 - Reichenbach, Hans ;   et al. | 2005-04-28 |
Epothilone side components App 20040049051 - Hoefle, Gerhard ;   et al. | 2004-03-11 |
Epothilone minor constituents Grant 6,624,310 - Hoefle , et al. September 23, 2 | 2003-09-23 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.